Updated progress in basic research of cell therapy for age-related macular degeneration
10.3760/cma.j.cn511434-20190124-00032
- VernacularTitle:老年性黄斑变性细胞疗法的基础研究进展
- Author:
Jingying PENG
1
;
Xiyuan ZHOU
Author Information
1. 重庆医科大学第二附属医院眼科 400061
- From:
Chinese Journal of Ocular Fundus Diseases
2020;36(8):661-664
- CountryChina
- Language:Chinese
-
Abstract:
Age-related macular degeneration (AMD) is a fundus disease characterized by degeneration of retinal photoreceptor cells, RPE cells and choroidal capillaries. The pathogenesis is not clear and there is no effective treatment. Cell therapies can slow or reverse the vision loss of AMD in animal models, which include implantation of bone marrow mesenchymal stem cells, pluripotent stem cells, RPE cells into the subretinal cavity. Therefore, cell therapy is a promising strategy for the treatment of AMD.
